Stockscreener 앱 받기
19.92
1.84%
0.36
시간 외 거래:
19.92
전일 마감가:
$19.56
열려 있는:
$19.8
하루 거래량:
42,605
Relative Volume:
1.14
시가총액:
$956.16M
수익:
-
순이익/손실:
$-75.28M
주가수익비율:
-9.9815
EPS:
-1.9957
순현금흐름:
$-57.45M
1주 성능:
+2.42%
1개월 성능:
+8.79%
6개월 성능:
+21.24%
1년 성능:
+66.69%
1일 변동 폭
$19.66
$20.14
1주일 범위
$19.00
$20.14
52주 변동 폭
$10.79
$23.08
Oculis Holding Ag Stock (OCS) Company Profile
OCS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OCS
Oculis Holding Ag
|
19.92 | 1.02B | 0 | -75.28M | -57.45M | -1.9957 |
|
ONC
Beone Medicines Ltd Adr
|
255.86 | 26.69B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
450.50 | 114.81B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.232 | 41.83M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
84.34 | 6.60B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
493.22 | 65.36B | 14.09B | 4.50B | 2.96B | 39.28 |
Oculis Holding Ag Stock (OCS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-12-05 | 개시 | Chardan Capital Markets | Buy |
| 2023-10-05 | 개시 | Stifel | Buy |
| 2023-06-14 | 개시 | BofA Securities | Buy |
| 2023-06-12 | 개시 | H.C. Wainwright | Buy |
| 2023-06-08 | 개시 | Robert W. Baird | Outperform |
| 2023-05-10 | 개시 | Pareto | Buy |
| 2023-04-28 | 개시 | Wedbush | Outperform |
모두보기
Oculis Holding Ag 주식(OCS)의 최신 뉴스
When the Price of (OCS) Talks, People Listen - news.stocktradersdaily.com
Oculis Holding AG Announces 2025 AGM Results and Strategic Approvals - TipRanks
Leerink Partners raises Oculis stock price target to $50 from $22 - Investing.com
Oculis Holding AG Reports Outcomes of 2025 Annual General Meeting and Shareholder Approvals - Nasdaq
Oculis Publishes Results of 2025 Annual General Meeting - The Manila Times
REG-Oculis Publishes Results of 2025 Annual General Meeting - TradingView
Citadel Advisors LLC Buys Shares of 22,911 Oculis Holding AG (NASDAQ:OCS) - Defense World
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities - marketscreener.com
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities - GlobeNewswire Inc.
Oculis to Participate in Upcoming June Investor Conferences - InvisionMag.com
Oculis Holding AG Announces Participation in Upcoming Investor Conferences in June 2025 - Nasdaq
REG-Oculis to Participate in Upcoming June Investor Conferences - TradingView
Trend Tracker for (OCS) - news.stocktradersdaily.com
Trend Tracker for (OCSAW) - news.stocktradersdaily.com
HC Wainwright Estimates Oculis’ Q2 Earnings (NASDAQ:OCS) - Defense World
HC Wainwright Weighs in on Oculis’ Q1 Earnings (NASDAQ:OCS) - Defense World
Oculis (NASDAQ:OCS) Sees Large Volume Increase on Analyst Upgrade - Defense World
Oculis (NASDAQ:OCS) Price Target Raised to $33.00 - Defense World
Oculis Publishes Invitation to the Annual General Meeting - The Manila Times
Oculis Holding AG (OCS) Reports Q1 Loss, Tops Revenue Estimates - MSN
Oculis Announces 2025 Annual General Meeting Details - TipRanks
Dave To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Friday - Benzinga
Oculis Reports Q1 2025 Financial Results and Provides Company Update - The Manila Times
Oculis Holding AG Reports Strong Q1 Progress - TipRanks
Learn to Evaluate (OCSAW) using the Charts - news.stocktradersdaily.com
Earnings Preview: Oculis Holding AG (OCS) Q1 Earnings Expected to Decline - MSN
Oculis Holding AG reports results for the quarter ended March 31Earnings Summary - TradingView
Oculis Holding AG Reports Q1 2025 Financial Results - TipRanks
Oculis to Present at Upcoming May Investor Conferences - EIN News
REG-Oculis to Present at Upcoming May Investor Conferences - TradingView
Long Term Trading Analysis for (OCS) - news.stocktradersdaily.com
Oculis (NASDAQ:OCS) Sees Unusually-High Trading Volume – Still a Buy? - Defense World
Oculis Holding AG (NASDAQ:OCS) Shares Bought by Geode Capital Management LLC - Defense World
Oculis to Present its Innovative Late-Stage Pipeline Candidates at Upcoming Ophthalmology Conferences - The Manila Times
Oculis Holding AG to Present Innovative Late-Stage Pipeline at Major Ophthalmology Conferences in 2025 - Nasdaq
Oculis Holding AG to Present Innovative Late-Stage Pipeline at Major Ophthalmology Conferences in May 2025 - Nasdaq
Oculis Updates Share Capital - The Manila Times
Long Term Trading Analysis for (OCSAW) - news.stocktradersdaily.com
(OCS) Trading Advice - news.stocktradersdaily.com
Chardan Capital Reaffirms Buy Rating for Oculis (NASDAQ:OCS) - Defense World
HC Wainwright Increases Oculis (NASDAQ:OCS) Price Target to $32.00 - Defense World
Oculis (NASDAQ:OCS) Shares Gap Up Following Analyst Upgrade - Defense World
Oculis and EURETINA Announce the 2025 Ramin Tadayoni Award - The Manila Times
Stifel maintains Buy rating, $35 target on Oculis shares By Investing.com - Investing.com South Africa
Stifel maintains Buy rating, $35 target on Oculis shares - Investing.com
Oculis Holding AG Unveils Key Clinical Updates and Future Outlook at R&D Day - TipRanks
Oculis Hosts R&D Event Today to Showcase Progress on All Three Pipeline Assets - The Manila Times
Oculis completes enrolment in trials for diabetic macular oedema eye drops - Yahoo
Oculis Holding Ag (OCS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.00%
2.33%
자본화:
|
볼륨(24시간):